The dual role of citrate in cancer

P Icard, L Simula, G Zahn, M Alifano… - Biochimica et Biophysica …, 2023 - Elsevier
Citrate is a key metabolite of the Krebs cycle that can also be exported in the cytosol, where
it performs several functions. In normal cells, citrate sustains protein acetylation, lipid …

[HTML][HTML] Targeting 2-oxoglutarate dehydrogenase for cancer treatment

LC Chang, SK Chiang, SE Chen… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Tricarboxylic acid (TCA) cycle, also called Krebs cycle or citric acid cycle, is an amphoteric
pathway, contributing to catabolic degradation and anaplerotic reactions to supply …

Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis

S Ahmed, CB Mahony, A Torres, J Murillo-Saich… - Arthritis Research & …, 2023 - Springer
Background Synovial fibroblasts in rheumatoid arthritis (RAFLS) exhibit a pathological
aberration of glycolysis and glutaminolysis. Henceforth, we aimed to investigate if dual …

Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development

L Gao, F Yang, D Tang, Z Xu, Y Tang, D Yang… - Journal of Experimental …, 2023 - Springer
Abstract Background Enolase 2 (ENO2) is a crucial glycolytic enzyme in cancer metabolic
process and acts as a “moonlighting” protein to play various functions in diverse cellular …

ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development

L Lang, R Loveless, J Dou, T Lam, A Chen… - Journal of Experimental …, 2022 - Springer
Background Targeting mitochondrial oncoproteins presents a new concept in the
development of effective cancer therapeutics. ATAD3A is a nuclear-encoded mitochondrial …

NAD+ Metabolism Generates a Metabolic Vulnerability in Endocrine-Resistant Metastatic Breast Tumors in Females

AN Mogol, Q Zuo, JY Yoo, AZ Kaminsky, OB Imir… - …, 2023 - academic.oup.com
Approximately 70% of human breast cancers express estrogen receptor-α (ERα), providing
a potential target for endocrine therapy. However, 30% to 40% of patients with ER+ breast …

Targeting the glutamine-arginine-proline metabolism axis in cancer

D Wang, J Duan, Y Guo, J Chen, T Chen… - Journal of Enzyme …, 2024 - Taylor & Francis
Metabolic abnormalities are an important feature of tumours. The glutamine-arginine-proline
axis is an important node of cancer metabolism and plays a major role in amino acid …

Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance

X Lin, W Zhou, Z Liu, W Cao, C Lin - Oral Diseases, 2023 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) is among the most prevalent cancer
worldwide, with the most severe impact on quality of life of patients. Despite the …

Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma

I Gupta, F Badrzadeh, Y Tsentalovich… - Journal of Experimental & …, 2024 - Springer
Oral squamous cell carcinoma (OSCC) accounts for around 90% of all oral cancers and is
the eighth most common cancer worldwide. Despite progress in managing OSCC, the …

HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer

F Chen, C Tang, F Yang, A Ekpenyong, R Qin, J Xie… - Science …, 2024 - science.org
Glycolytic metabolism may account for antitumor immunity failure. Pyruvate kinase M2
(PKM2) and platelet phosphofructokinase (PFKP), two key enzymes involved in the …